Asthma Flashcards

1
Q

Asthma

A

Chronic d/o characterized by recurring episodes of airway obstruction d/t smooth muscle hyperresponsiveness and mucosal inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Epidemiology of Asthma

A

-affects ~1/10 5-17yo
-boys > girls; women > men
-Puerto Rican > Black > White > Mexican
-Complete remission occurs in 1/4 of kids (often near puberty)
-if sx onset 50yo+, consider other dx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MC stimuli of Asthma attacks

A

-ragweed
-animal dander
-house dust (dust mites and cockroaches)
-mold
-exercise, esp in cold air

*LOTS of others (RSV, rhinovirus, sulfiting agents, tartrazine (yellow 5), reflux, nonselective BB, ACEI, ASA, menstrual phases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are 2 other conditions often associated with Asthma

A

Atopic dermatitis (eczema)
Seasonal allergies

*if FH of either consider asthma risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Asthma: typical S/S on lung exam

A

-wheezing (“whistling” on expiration)
-cough (usu worse at night)
-dyspnea
-chest tightness (trapped air)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Asthma: Ominous signs (more concerning)

A

-hyperresonance w/ percussion
-tachypnea & tachycardia
-use of accessory muscles
-prolonged expiratory phase
-quiet chest (lack of air mvmt)
-pulsus paradoxus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Asthma: PE findings (other than lung exam)

A

-pale, swollen nasal mucosa & cobblestoned posterior pharynx suggest allergic rhinitis
-atopic dermatitis in a flexural distribution
-nasal polyps (check for ASA sensitivity!!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Asthma: Dx tests

A

PFT (measures lung volume, capacity, flow rate, gas exchange):
1. spirometry (MC)
2. plethysmography

*measures FRC, TLC, FEV1, FVC, FEF (Forced expiratory flow = avg forced expiratory rate during mid-FVC/aka forced expiration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are expected values of FEV1, FVC, and FEV1/FVC in obstructive & restrictive pulm dz?

A

OBSTRUCTIVE:
low FEV1
normal FVC
low FEV1/FVC

RESTRICTIVE:
variable FEV1
low FVC (little air inspired initially)
high FEV1/FVC ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Spirometry: Flow-Loop Volume Patterns

A

Y-axis: flow rate
X-axis: volume
*most useful in dx obstruction (i.e. decreased expiratory flow)

OBSTRUCTIVE: scoop on expiration, high volume (shift left)

RESTRICTIVE: smaller volume overall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the “gold standard” dx test for asthma

A

Measurement of airway reactivity before and after a methacholine or histamine challenge (triggers asthma)
-only perform is spirometry is normal or if atypical sx (e.g. cough is only sx)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is allergy testing used in dx of asthma

A

Allergy skin testing may identify triggers, but will NOT make the asthma dx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

NAEPP recommendations for preferred step therapy in asthma pts 12yo+ (KNOW THIS)

A

Step 1 (Intermittent): SABA prn

Step 2 (mild persistent): daily low-dose ICS & SABA prn OR concomitant ICS & SABA prn

Step 3 (moderate persistent): daily & prn low-dose ICS-formoterol (SMART)

Step 4 (severe persistent): daily & prn medium-dose ICS-formoterol (SMART)

Step 5 (severe persistent): daily medium- to high-dose ICS-LABA + LAMA; and SABA prn

Step 6 (severe persistent): daily high-dose ICS-LABA + oral systemic corticosteroids and SABA prn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Classification of Asthma Severity by Sx and Lung Fxn when not on tx (intermittent, mild persistent, moderate persistent, severe persistent - day & night sx, FEV1 value, 1st line tx)

A

INTERMITTENT
Day sx: 2 or < days/wk
Night sx: 2 or < nights/mo
FEV1: >80% predicted
Tx: SABA prn

MILD PERSISTENT
Day sx: 3-6 days/wk
Night sx: 3-4 nights/mo
FEV1: 80%+ predicted
Tx: low-dose ICS

MODERATE PERSISTENT
Day sx: daily
Night sx: >1/wk but not nightly
FEV1: 60-80%
Tx: low-dose ICS-LABA or medium-dose ICS

SEVERE PERSISTENT
Day sx: throughout day
Night sx: often nightly
FEV1: <60%
Tx: medium-dose ICS-LABA –> high-dose ICS-LABA –> high-dose ICS-LABA + oral corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Asthma: Management (drugs designed to relax tracheobronchial smooth muscle)

A

-beta-adrenergic agonists
-theophylline
-anticholinergics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Asthma: Management (drugs that fight inflammation)

A

-corticosteroids
-cromolyn sodium
-nedocromil
-leukotriene inhibitors

17
Q

Beta-adrenergic agonists (increase symNS)

A

Selective B2 agonists
-SABA: Albuterol
-LABA: Salmeterol & Formoterol ***NEVER use w/o an ICS

EPI used only for acute relief of severe airflow obstruction (EpiPen)

18
Q

Theophylline

A

uncommonly used d/t SE/necessary monitoring (may cause arrhythmias, sz)

19
Q

Anticholinergic agents

A

ipratropium, tiotropium
-can sub for LABA in LABA/ICS if pt doesn’t tolerate LABA

20
Q

Systemic steroids

A

used only for 1-3 wks to tx exacerbations
-avoid long term maintenance

21
Q

Inhaled corticosteroids (ICS)

A

-available in combo w/ LABA
Advair
Dulera
Symbicort

22
Q

Leukotriene inhibitors

A

-less effective than ICS for treating inflammation
-oral meds; can be used if pt has trouble w/ inhalers
ex. Montelukast (Singulair)

23
Q

Humanized monoclonal antibody against IgE

A

Omalizumab (Xolair)
-use only in pt w/ atopy (atopic dermatitis) during allergy testing